REQUEST A DEMO
Total
USD $0.00
Search more companies

Srikar Chem & Pharma India Private Limited (India)

Main Activities: Basic Chemical Manufacturing
Full name: Srikar Chem & Pharma India Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Srikar Chem & Pharma India Private Limited is an unlisted company, incorporated on 01/02/2011. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24100TG2011PTC072439 and registration number is 072439. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Dno:2-133/2, Flat No:215, Nirmal Ratna Apartments Gangaram,Chandanagar
Hyderabad; Telangana; Postal Code: 500050

Contact Details: Purchase the Srikar Chem & Pharma India Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Srikar Chem & Pharma India Private Limited report to view the information.
Outstanding Shares:
Purchase the Srikar Chem & Pharma India Private Limited report to view the information.
Registered Capital:
Purchase the Srikar Chem & Pharma India Private Limited report to view the information.
Incorporation Date:
February 01, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Srikar Chem & Pharma India Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-10.75%
Total operating revenue
-10.75%
Operating profit (EBIT)
-32.4%
EBITDA
-18.54%
Net Profit (Loss) for the Period
-32.03%
Total assets
-1.76%
Total equity
3.48%
Operating Profit Margin (ROS)
-0.82%
Net Profit Margin
-0.59%
Return on Equity (ROE)
-1.75%
Debt to Equity Ratio
-1.9%
Quick Ratio
0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?